Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.85
- Piotroski Score 7.00
- Grade Buy
- Symbol (MTLS)
- Company Materialise NV
- Price $7.35
- Changes Percentage (-1.74%)
- Change -$0.13
- Day Low $7.33
- Day High $7.51
- Year High $7.56
Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/19/2025
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.12
- Trailing P/E Ratio 42.33
- Forward P/E Ratio 42.33
- P/E Growth 42.33
- Net Income $6.72 M
Income Statement
Quarterly
Annual
Latest News of MTLS
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Shareholders Will Be Pleased With The Quality of Materialise's (NASDAQ:MTLS) Earnings
Materialise NV (NASDAQ:MTLS) reported strong earnings, with potential for future profitability. Unusual items impacted profit, but these are not likely to be repeated. Analysts' forecasts and company ...
By Yahoo! Finance | 3 weeks ago -
Results: Materialise NV Beat Earnings Expectations And Analysts Now Have New Forecasts
Materialise NV exceeded revenue and EPS estimates in its latest results, with analysts forecasting a positive outlook for 2025. Despite improved earnings, the stock valuation remains steady. Analysts ...
By Yahoo! Finance | 3 weeks ago -
Materialise NV (MTLS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Driven by Medical ...
Koen Berges, CFO, mentions Medical segment EBITDA margins at around 30%, while CEO Brigitte de Vet-Veithen highlights a shift in Manufacturing focus to boost margins....
By Yahoo! Finance | 4 weeks ago
